These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4298116)

  • 1. [On the neurotropic behavior of foot-and-mouth disease standard A virus after intracerebral inoculation. 3. Development of a virus strain with neurotropic properties for the guinea pig].
    Veckenstedt A; Urbaneck D
    Arch Exp Veterinarmed; 1966 Sep; 20(4):731-50. PubMed ID: 4298116
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the development of myotropic foot-and-mouth disease virus strains in guinea pigs].
    Bengelsdorff HJ; Schneider B
    Zentralbl Bakteriol Orig; 1964 Nov; 194(3):292-305. PubMed ID: 4284150
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biological properties of virus strains, reproduced from infectious ribonucleic acid neurotropic foot-and-mouth disease virus mutants].
    Veckenstedt A; Hantschel H
    Arch Exp Veterinarmed; 1966 Jun; 20(3):581-7. PubMed ID: 4296901
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antigenic properties of foot-and-mouth disease virus strain Ai].
    Darda PN; Salazhov EL; Antoniuk VP; Likhachev NV
    Veterinariia; 1966 Jan; 43(1):20-2. PubMed ID: 4293892
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of cross reacting isolates of foot & mouth disease virus.
    Venkataramanan R; Mukhopadhyay AK; Rao BU
    Indian J Exp Biol; 1983 Mar; 21(3):137-42. PubMed ID: 6197366
    [No Abstract]   [Full Text] [Related]  

  • 6. [Classification of the foot-and-mouth disease virus strain responsible for the 1967 English epidemic].
    Böhm HO; Panjevic D
    Berl Munch Tierarztl Wochenschr; 1970 Nov; 83(21):409-14. PubMed ID: 4319822
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunochemical studies of foot and mouth disease. I. Complement fixation reactions with isolated antigenic components.
    Cowan KM; Trautman R
    J Immunol; 1967 Oct; 99(4):729-36. PubMed ID: 4293091
    [No Abstract]   [Full Text] [Related]  

  • 8. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE; Cunliffe HR; Bachrach HL
    Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antigenic properties of some strains of foot-and-mouth disease virus].
    Bazadze TsV
    Veterinariia; 1971 Aug; 9():34-5. PubMed ID: 4334672
    [No Abstract]   [Full Text] [Related]  

  • 10. Differentiation of type A foot-and-mouth disease virus subtypes by double- and radial-immunodiffusion analysis.
    Lobo CA; Cowan KM; Trautman R; Hanson RP
    Am J Vet Res; 1974 Aug; 35(8):1121-6. PubMed ID: 4368590
    [No Abstract]   [Full Text] [Related]  

  • 11. [Subtypes of the foot-and-mouth disease virus type O. Their antigenic and immunologic properties and mutual relationships].
    Wittmann G
    Zentralbl Bakteriol Orig; 1964 Sep; 194(1):1-25. PubMed ID: 4284199
    [No Abstract]   [Full Text] [Related]  

  • 12. [Viral particle specific serums, used in complement fixation tests of foot-and-mouth disease virus].
    Roumiantzeff M; Fayet MT
    Ann Inst Pasteur (Paris); 1969 Jun; 116(6):833-51. PubMed ID: 4312138
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transmissibility of infectious ribonucleic acid from neurotropic foot-and-mouth disease virus from murine brains to the brains of small laboratory animals].
    Hantschel H
    Arch Exp Veterinarmed; 1968; 22(3):491-7. PubMed ID: 4304281
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relationship between the chemical structure and the biological activity of antibodies against the foot-and-mouth disease virus].
    Veleva EB
    Vet Med Nauki; 1977; 14(2):89-94. PubMed ID: 199988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of nanogram to milligram quantities of inactivated foot-and-mouth disease virus. II. Comparative response of guinea pigs and steers.
    Morgan DO; McKercher PD; Bachrach HL
    Proc Annu Meet U S Anim Health Assoc; 1968; 72():407-15. PubMed ID: 4308554
    [No Abstract]   [Full Text] [Related]  

  • 16. [Foot-and-mouth disease in Ethiopia. Distribution of serotypes of foot-and-mouth disease virus].
    Martel JL
    Rev Elev Med Vet Pays Trop; 1974; 27(2):169-75. PubMed ID: 4377719
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antigenic properties of strains of A 22 foot-and-mouth disease virus isolated in epizootic conditions].
    Salajov EL; Antoniouk VP
    Bull Off Int Epizoot; 1972; 77(5):929-34. PubMed ID: 4350008
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of a method for the quantitative determination of the immunizing antigen (140S) of the foot-and-mouth disease virus].
    Tekerlekov P; Vasileva L; Nikolova E; Veleva E
    Vet Med Nauki; 1985; 22(9):10-9. PubMed ID: 3002008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological behaviour of cross reacting foot & mouth disease virus isolates.
    Venkataramanan R; Mukhopadhyay AK; Rao BU
    Indian J Exp Biol; 1983 Mar; 21(3):134-6. PubMed ID: 6197365
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antigenic and immunological relationships between the A sub-types of the foot-and-mouth disease virus. 1. After inoculation of guinea-pigs with active virus].
    Wittmann G
    Zentralbl Veterinarmed B; 1966 Jun; 13(3):225-38. PubMed ID: 4290978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.